IDENTIFICATION OF RESIDUES IN THE V-DOMAIN OF CD80 (B7-1) IMPLICATED IN FUNCTIONAL INTERACTIONS WITH CD28 AND CTLA4

被引:48
作者
FARGEAS, CA
TRUNEH, A
REDDY, M
HURLE, M
SWEET, R
SEKALY, RP
机构
[1] INST RECH CLIN MONTREAL, IMMUNOL LAB, MONTREAL, PQ H2W 1R7, CANADA
[2] SMITHKLINE BEECHAM PHARMACEUT, DEPT MOLEC IMMUNOL, KING OF PRUSSIA, PA 19406 USA
[3] SMITHKLINE BEECHAM PHARMACEUT, DEPT MACROMOLEC SCI, KING OF PRUSSIA, PA 19406 USA
[4] UNIV MONTREAL, FAC MED, DEPT MICROBIOL & IMMUNOL, MONTREAL, PQ H3C 3J7, CANADA
[5] MCGILL UNIV, SCH MED, DEPT MICROBIOL & IMMUNOL, MONTREAL, PQ H3A 2B4, CANADA
关键词
D O I
10.1084/jem.182.3.667
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The CD80 (B7-1) molecule is a 45-60-kD member of the immunoglobulin superfamily that is expressed on a variety of cell types of haematopoietic origin. CD80 can provide a critical costimulatory signal to T cells by interacting with the T cell surface molecule CD28. CD80 also binds to the CD28-related molecule CTLA4, which is expressed on activated T cells. Recently, additional ligands of CD28 and CTLA4 have been described in mice and humans. One of them, CD86 (B-70 or B7-2) was characterized at the molecular level. Although similar in predicted structure to CD80, it is distantly related in amino acid sequence. In this study, human CD80 mutants were generated and tested for their ability to maintain the interaction with CD28 leading to adhesion and enhanced IL-2 production. Two hydrophobic residues in the V-like domain of CD80 were identified as critical for binding to CD28 and are also important for the interaction with CTLA4. These residues are adjacent to the epitope of the BB1 antibody, which inhibits CD28-CD80 interactions. One of these residues, Y87, is conserved in all CD80 and CD86 cloned from various species. These results begin to unravel the structural requirements for binding to CD28 and CTLA4.
引用
收藏
页码:667 / 675
页数:9
相关论文
共 37 条
[1]   CD28-B7 INTERACTIONS IN T-CELL ACTIVATION [J].
ALLISON, JP .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (03) :414-419
[2]   3-DIMENSIONAL STRUCTURE OF AN ANTIGEN-ANTIBODY COMPLEX AT 2.8-A RESOLUTION [J].
AMIT, AG ;
MARIUZZA, RA ;
PHILLIPS, SEV ;
POLJAK, RJ .
SCIENCE, 1986, 233 (4765) :747-753
[3]  
AZUMA M, 1992, J IMMUNOL, V149, P1115
[4]   B70 ANTIGEN IS A 2ND LIGAND FOR CTLA-4 AND CD28 [J].
AZUMA, M ;
ITO, D ;
YAGITA, H ;
OKUMURA, K ;
PHILLIPS, JH ;
LANIER, LL ;
SOMOZA, C .
NATURE, 1993, 366 (6450) :76-79
[5]   A NEW MEMBER OF THE IMMUNOGLOBULIN SUPERFAMILY - CTLA-4 [J].
BRUNET, JF ;
DENIZOT, F ;
LUCIANI, MF ;
ROUXDOSSETO, M ;
SUZAN, M ;
MATTEI, MG ;
GOLSTEIN, P .
NATURE, 1987, 328 (6127) :267-270
[6]   STRUCTURE OF DOMAIN-1 OF RAT LYMPHOCYTE-T CD2 ANTIGEN [J].
DRISCOLL, PC ;
CYSTER, JG ;
CAMPBELL, ID ;
WILLIAMS, AF .
NATURE, 1991, 353 (6346) :762-765
[7]   THE B7-2 (B70) COSTIMULATORY MOLECULE EXPRESSED BY MONOCYTES AND ACTIVATED B-LYMPHOCYTES IS THE CD86 DIFFERENTIATION ANTIGEN [J].
ENGEL, P ;
GRIBBEN, JG ;
FREEMAN, GJ ;
ZHOU, LJ ;
NOZAWA, Y ;
ABE, M ;
NADLER, LM ;
WAKASA, H ;
TEDDER, TF .
BLOOD, 1994, 84 (05) :1402-1407
[8]  
FREEMAN GJ, 1989, J IMMUNOL, V143, P2714
[9]   CLONING OF B7-2 - A CTLA-4 COUNTER-RECEPTOR THAT COSTIMULATES HUMAN T-CELL PROLIFERATION [J].
FREEMAN, GJ ;
GRIBBEN, JG ;
BOUSSIOTIS, VA ;
NG, JW ;
RESTIVO, VA ;
LOMBARD, LA ;
GRAY, GS ;
NADLER, LM .
SCIENCE, 1993, 262 (5135) :909-911
[10]   STRUCTURE, EXPRESSION, AND T-CELL COSTIMULATORY ACTIVITY OF THE MURINE HOMOLOG OF THE HUMAN LYMPHOCYTE-B ACTIVATION ANTIGEN-B7 [J].
FREEMAN, GJ ;
GRAY, GS ;
GIMMI, CD ;
LOMBARD, DB ;
ZHOU, LJ ;
WHITE, M ;
FINGEROTH, JD ;
GRIBBEN, JG ;
NADLER, LM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (03) :625-631